Babesia Microti IgM Titer

Fever, chills, or fatigue after time in tick country can have several causes. Babesia microti is one possibility, particularly in the northeastern and upper midwestern United States. This antibody test can support an investigation of babesiosis, but a positive result alone doesn't establish that the parasite is causing your symptoms.

Infection can cause mild illness or no symptoms. It can also become severe, especially if you're older, don't have a functioning spleen, or have a weakened immune system. The same blacklegged tick that spreads Lyme disease can transmit this parasite, and standard Lyme testing doesn't test for it.

What the Result Measures

Babesia microti is a single-celled parasite that infects red blood cells and causes babesiosis. IgM is a class of antibody that can appear early in the immune response. IgG is another antibody class that often remains detectable longer. Their timing overlaps, so the combination cannot reliably date an infection.

This test measures IgM antibodies against B. microti in serum collected through a blood draw. Serum is the liquid left after blood clots. The method is indirect immunofluorescence (IFA). The lab dilutes the serum step by step and uses a fluorescent microscope to check whether its antibodies react with parasite-infected cells.

The titer is the greatest dilution that still produces a positive reaction. It's reported as a ratio. Within the same assay, a larger second number indicates stronger antibody reactivity. It doesn't measure how many parasites are in your blood or how severe your illness is.

IgM can suggest a recent or ongoing immune response, but false-positive results occur. For suspected acute babesiosis, the established diagnostic tests are a blood smear and PCR. A smear looks for parasites inside red blood cells. PCR looks for the parasite's genetic material in whole blood. These directly assess infection and answer a different question from the serum antibody titer.

Babesiosis and Who Gets Seriously Ill

Babesiosis can destroy red blood cells faster than your body replaces them, causing anemia. Platelet counts can also fall. Severe infection can affect breathing, kidney function, and other organs. Transmission occurs mainly through infected ticks, but it can also occur through blood transfusions and, rarely, from mother to baby during pregnancy.

Your spleen and immune function strongly affect the course of the illness. People without a functioning spleen and those receiving treatments that suppress antibody-making cells, especially rituximab, are at greater risk of severe or relapsing infection. A weak or absent antibody response can occur in these same high-risk groups.

The following studies describe confirmed or recorded babesiosis. Their findings don't estimate your risk from an isolated positive IgM result.

In the multicenter cohort, blood cancer was associated with about sevenfold higher odds of recurrence. That estimate came from a small number of recurrences and describes a group association, not an individual forecast. The higher one-year mortality in this cohort included deaths from causes other than babesiosis.

Lyme Disease and Other Tick Infections

The blacklegged tick can transmit Lyme bacteria, B. microti, and Anaplasma phagocytophilum. A single exposure can therefore lead to more than one infection. A New York study of 52 adults with untreated early Lyme disease found convincing evidence of B. microti coinfection in four people, or 7.7%. That assessment used IgG antibody changes and direct parasite testing, not isolated IgM positivity.

Two positive antibody tests still need separate interpretation. Older studies found little cross-reaction between Lyme and Babesia tests under their study conditions, but a published case documented a temporary false-positive Lyme IgM result during babesiosis. Antibodies can also reflect earlier exposures. Two positive results alone don't establish two active infections.

Studies of coinfection have reached different conclusions about illness severity. In a U.S. records study of 3,521 people with babesiosis, another tick-borne diagnosis was associated with lower odds of death within 90 days. The adjusted odds were 57% lower. The comparison included Lyme disease, ehrlichiosis, and anaplasmosis, although Lyme disease was by far the most common.

That observational finding doesn't show that coinfection protects you. Earlier recognition, differences in treatment, and differences between the groups could explain it. The study also lacked adequate information on parasite burden. Its suggestion that doxycycline contributed to the finding remains a hypothesis; doxycycline alone is not an established treatment for B. microti infection.

A separate long-term study found no worse persistent symptoms among people with a history of Lyme disease and antibody evidence of Babesia exposure. Because antibody evidence doesn't establish simultaneous active infection, that finding cannot settle how an acute coinfection will affect you.

Silent Infection and the Blood Supply

People who feel well can still carry B. microti. Longitudinal studies using parasite DNA testing and other direct methods have documented low-level infection lasting months, occasionally more than two years. Antibody persistence and parasite persistence are different findings, and an IgM titer alone cannot establish whether your blood remains infectious.

Transfusion recipients often have conditions that make babesiosis more dangerous. U.S. blood banks in designated risk regions use specialized tests for Babesia genetic material to reduce transmission. This donor screening serves a different purpose from a clinical IgM antibody test.

How Accurate the Test Is

A 1996 evaluation of B. microti IgM IFA reported 91% sensitivity and 99% specificity. In that study, the test detected about nine in ten infections and was negative in about 99 in 100 people without infection. Those findings support its use as an antibody test, but they don't mean that every positive result has a 99% chance of representing active babesiosis.

The chance that a positive result represents infection also depends on your symptoms and exposure history. Testing people with little reason to suspect infection produces a larger share of false-positive results among the positives.

A separate study of broader B. microti antibody testing across four laboratories reported sensitivity of 88% to 96% and specificity of 90% to 100%. Those estimates were not an evaluation of this IgM measurement alone, and they also illustrate why results from different assays aren't interchangeable.

Antibodies can be absent early in infection. PCR is particularly useful when few parasites are circulating, and it can detect infection before antibodies appear. Blood smears remain useful because they can show the parasites and estimate the proportion of infected red blood cells. Neither method detects every infection in every sample.

When Results Can Be Misleading

• Early infection: antibodies may not yet be detectable when symptoms begin, so an early negative IgM result cannot exclude babesiosis.
• Isolated IgM positivity: a positive IgM result without supporting IgG or direct parasite evidence can be false positive. Nonspecific antibody reactions and interference from antibodies such as rheumatoid factor can affect IFA testing.
• Suppressed antibody production: rituximab and other causes of impaired immunity can blunt the response despite active infection.
• Persistent antibody responses: a positive antibody result can outlast the illness. The IgM and IgG pattern alone cannot reliably establish when infection occurred or whether it has cleared.
• Other Babesia species: this assay targets B. microti. It does not reliably exclude infections caused by other species, including B. duncani and B. divergens.
• Assay differences: antigen preparations, interpretation of fluorescence, and laboratory procedures can affect titers. Small differences between laboratories or methods may not represent a biological change.

What Changes Over Time

Paired antibody samples can help document a developing immune response. The established paired-antibody criterion for recent B. microti infection concerns a rise in IgG, not a validated IgM trend that predicts parasite clearance.

IgG can remain detectable for a year or longer after infection. A positive IgG with negative IgM can fit past exposure, but it cannot by itself exclude ongoing infection. IgM is not a validated test of cure, and a falling titer should not determine whether treatment has worked.